首页 | 本学科首页   官方微博 | 高级检索  
     


Review article: dose optimisation of infliximab for acute severe ulcerative colitis
Authors:P. Hindryckx  G. Novak  N. Vande Casteele  D. Laukens  C. Parker  L. M Shackelton  N. Narula  R. Khanna  P. Dulai  B. G Levesque  W. J Sandborn  G. D'Haens  B. G. Feagan  V. Jairath
Affiliation:1. Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada;2. Department of Gastroenterology, University of Ghent, Ghent, Belgium;3. Department of Gastroenterology, Ljubljana University Medical Centre, Ljubljana, Slovenia;4. Department of Medicine and Farncombe Family Digestive Health Research Institute, Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada;5. Department of Medicine, University of Western Ontario, London, Ontario, Canada;6. Division of Gastroenterology, University of California San Diego, La Jolla, California, USA;7. Inflammatory Bowel Disease Centre, Academic Medical Centre, Amsterdam, The Netherlands;8. Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号